RBI
BIIB icon

Raiffeisen Bank International’s Biogen BIIB Stock Holding History

Raiffeisen Bank International’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9K Hold
78
– – ﹤0.01% 677
2026
Q1 		$14.3K Hold
78
– – ﹤0.01% 691
2025
Q4 		$11.6K Hold
78
– – ﹤0.01% 719
2025
Q3 		$10.9K Buy
+78
New +$10.5K ﹤0.01% 740

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Raiffeisen Bank International's BIIB Position: Q2 2026 in Review

Raiffeisen Bank International increased its Biogen (BIIB) stake by 7.6% in Q2 2026, buying an estimated $1.53K and bringing the position to 113 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Raiffeisen Bank International first reported a position in BIIB in Q4 2024 and has held it in 5 quarters since. The position peaked at $236K in Q4 2024. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Raiffeisen Bank International held 113 shares of Biogen worth $24.5K as of Q2 2026.
  • Raiffeisen Bank International bought 8 Biogen shares in Q2 2026, an estimated $1.53K.
  • Biogen made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #653 holding.
  • Raiffeisen Bank International first reported a position in Biogen in Q4 2024 and has held it in 5 quarters since.
  • Raiffeisen Bank International's Biogen position peaked at $236K in Q4 2024.
  • 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.